Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Contract Renewals

7 Feb 2006 07:00

e2v technologies PLC07 February 2006 7 February 2006 e2v secures two contract renewals worth £21m e2v technologies announces it has won two contract renewals worth a total of£21m. Both contracts are for existing OEM customers and are for products within e2v'selectronic tubes product group for use within radiotherapy cancer treatmentsystems. These products generate and deliver the exceptional levels of microwave powerrequired to drive the linear accelerator within radiotherapy systems, whichconvert the microwave power to X-rays used both in the imaging and radiationtreatment of tumours. e2v has been supporting this important application for inexcess of 30 years and works closely with OEM customers to improve theperformance and reliability of their systems. The largest of the contracts, worth £17m, and with delivery over a 3 yearperiod, is to supply Elekta, headquartered in Sweden with manufacturingfacilities in the UK and China. The second contract, worth $7m (£4m), is with TomoTherapy(R) Inc, based inWisconsin, USA. Delivery is scheduled over a 12 month period. Keith Attwood, Chief Executive of e2v said: "The renewal of these two contracts reinforces our position as a strategicsupplier into the radiotherapy equipment market and is entirely consistent withguidance given in our Interim Report and Accounts issued in December 2005." For further information: e2v technologies plc Tel: 01245 493493Keith Attwood/Mike Hannantwww.e2v.com Gavin Anderson & Company Tel: 020 7554 1400Charlotte Stone/Keith Brookbank NOTES FOR EDITORS e2v technologies plc e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. It is listed on the London Stock Exchange(e2v.l). e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into three core areas: •Medical & Science : Sensor technology includes Dental X-ray, Mammography, life science applications and X-ray microscopy. Electronic Tubes are the enabling technology behind radiotherapy cancer treatments, microwave medical therapy and high-energy physics. •Aerospace & Defence : Sensor technology includes military surveillance, targeting and guidance; space-based imaging and astronomy and radar & electronic warfare. Electronic tubes provide the enabling technology behind radars, electronic countermeasures (ECM), electronic warfare and satellite communications. •Commercial & Industrial : Sensor technology includes marine radars, industrial safety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters. Electronic tubes provide enabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. e2v has 1,300 employees worldwide with offices in UK, USA, Germany, France,Canada and a presence in China through the China Britain Business Council, aswell as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 20105:10 pmRNSHolding(s) in Company
1st Apr 20107:00 amRNSUpdate on Restructuring
29th Mar 20103:10 pmRNSHolding(s) in Company
22nd Mar 20104:35 pmRNSPrice Monitoring Extension
19th Mar 20104:37 pmRNSPrice Monitoring Extension
11th Mar 20104:08 pmRNSTotal Voting Rights
8th Mar 20104:25 pmRNSDirector/PDMR Shareholding
5th Mar 20102:55 pmRNSDirector/PDMR Shareholding
1st Mar 20107:00 amRNSUpdate on Restructuring
17th Feb 201011:15 amRNSTotal Voting Rights
2nd Feb 20107:00 amRNSInterim Management Statement
22nd Jan 20102:15 pmRNSHolding(s) in Company
19th Jan 201010:01 amRNSTotal Voting Rights
18th Dec 20093:55 pmRNSHolding(s) in Company
16th Dec 20092:31 pmRNSNOTIFICATION OF MAJOR INTERESTS IN SHARES
15th Dec 20094:25 pmRNSDirector/PDMR Shareholding
10th Dec 20094:27 pmRNSTotal Voting Rights
9th Dec 20095:33 pmRNSHolding(s) in Company
9th Dec 20095:32 pmRNSHolding(s) in Company
9th Dec 20095:29 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
9th Dec 20095:25 pmRNSHolding(s) in Company
8th Dec 20095:32 pmRNSHolding(s) in Company
8th Dec 20095:26 pmRNSHolding(s) in Company
8th Dec 200910:03 amRNSResults of Rump Placing
8th Dec 20097:00 amRNSResults of Rights Issue
4th Dec 20092:26 pmBUSDisclosure of Short Position
2nd Dec 20093:23 pmRNSNotification of Transactions of Directors
2nd Dec 20091:58 pmBUSDisclosure of Short Position
27th Nov 200911:04 amRNSNotification of Transaction by Directors
25th Nov 20093:45 pmRNSNotification of Major Interests in Shares
25th Nov 20093:43 pmRNSNotification of Major Interests in Shares
25th Nov 20093:42 pmRNSNotification of Major Interests in Shares
25th Nov 20093:39 pmRNSNotification of Major Interests in Shares
25th Nov 20093:35 pmRNSNotification of Major Interests in Shares
20th Nov 20094:40 pmRNSSecond Price Monitoring Extn
20th Nov 20094:35 pmRNSPrice Monitoring Extension
20th Nov 200910:33 amRNSResults of General Meeting
10th Nov 20091:53 pmRNSTotal Voting Rights
6th Nov 20091:12 pmRNSProspectus Clarification
5th Nov 20094:20 pmRNSNotification of Major Interests in Shares
4th Nov 20094:41 pmRNSNotification of Major Interests in Shares
2nd Nov 20094:45 pmRNSPublication of Prospectus
2nd Nov 20093:39 pmRNSNotification of Major Interests in Shares
29th Oct 20094:40 pmRNSSecond Price Monitoring Extn
29th Oct 20094:35 pmRNSPrice Monitoring Extension
29th Oct 20097:10 amRNSInterim Results
29th Oct 20097:10 amRNSFirm Placing and Rights Issue
9th Oct 20097:00 amRNSPeriod End Update
7th Oct 200911:51 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.